Chief Business Officer And Chief Financial Officer Fang Ni And Chief People Officer Elizabeth Montgomery Are Departing The Co; Erika Jones, Senior Vice President Of Finance And Principal Accounting Officer, Has Been Appointed Principal Financial Officer
Chief Business Officer And Chief Financial Officer Fang Ni And Chief People Officer Elizabeth Montgomery Are Departing The Co; Erika Jones, Senior Vice President Of Finance And Principal Accounting Officer, Has Been Appointed Principal Financial Officer
Black Diamond is actively seeking partnerships as it deprioritizes its BDTX-4933 program in RAF/RAS-mutant solid tumors. To enable focused investment in BDTX-1535, Black Diamond has also taken steps to optimize operations, including a reduction in force, while retaining core drug development and management expertise. As part of the restructuring, Chief Business Officer and Chief Financial Officer Fang Ni and Chief People Officer Elizabeth Montgomery are departing the Company. Erika Jones, Senior Vice President of Finance and Principal Accounting Officer, has been appointed Principal Financial Officer of the Company. Cost savings from the restructuring and other actions described above are expected to be sufficient to fund operations into Q2 2026.
Black Diamond正在積極尋求合作伙伴，將其在RAF/RAS突變實體腫瘤中的BDTX-4933項目降低優先級。爲了專注投資於BDTX-1535，Black Diamond還採取了優化運營的措施，包括減少人員編制，同時保留核心藥物開發和管理專業知識。作爲重組的一部分，業務首席執行官兼首席財務官方妮和首席人力官伊麗莎白·蒙哥馬利即將離開公司。財務高級副總裁兼首席會計官埃裏卡·瓊斯已被任命爲公司的信安金融長。預計從上述重組和其他行動中實現的成本節省將足以支持業務運營至2026年第二季度。
譯文內容由第三人軟體翻譯。
